Leviton et al., 1995 - Google Patents
Tobramycin uptake in Escherichia coli membrane vesiclesLeviton et al., 1995
View PDF- Document ID
- 13401244670064494610
- Author
- Leviton I
- Fraimow H
- Carrasco N
- Dougherty T
- Miller M
- Publication year
- Publication venue
- Antimicrobial agents and chemotherapy
External Links
Snippet
The uptake of tobramycin was measured in Escherichia coli membrane vesicles prepared in KMES [K (+)-2-(N-morpholino) ethanesulfonic acid] buffer at pH 6.6. Uptake occurred in vesicles energized with ascorbic acid and phenazine methosulfate, in which the electrical …
- 229960000707 Tobramycin 0 title abstract description 68
Classifications
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by the preceding groups
- G01N33/48—Investigating or analysing materials by specific methods not covered by the preceding groups biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/5005—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells
- G01N33/5008—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells for testing or evaluating the effect of chemical or biological compounds, e.g. drugs, cosmetics
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by the preceding groups
- G01N33/48—Investigating or analysing materials by specific methods not covered by the preceding groups biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/53—Immunoassay; Biospecific binding assay
- G01N33/569—Immunoassay; Biospecific binding assay for micro-organisms, e.g. protozoa, bacteria, viruses
- G01N33/56911—Bacteria
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N2333/00—Assays involving biological materials from specific organisms or of a specific nature
- G01N2333/195—Assays involving biological materials from specific organisms or of a specific nature from bacteria
- G01N2333/24—Assays involving biological materials from specific organisms or of a specific nature from bacteria from Enterobacteriaceae (F), e.g. Citrobacter, Serratia, Proteus, Providencia, Morganella, Yersinia
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES OR MICRO-ORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or micro-organisms; Compositions therefor; Processes of preparing such compositions
- C12Q1/02—Measuring or testing processes involving enzymes, nucleic acids or micro-organisms; Compositions therefor; Processes of preparing such compositions involving viable micro-organisms
- C12Q1/025—Measuring or testing processes involving enzymes, nucleic acids or micro-organisms; Compositions therefor; Processes of preparing such compositions involving viable micro-organisms for testing or evaluating the effect of chemical or biological compounds, e.g. drugs, cosmetics
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES OR MICRO-ORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or micro-organisms; Compositions therefor; Processes of preparing such compositions
- C12Q1/02—Measuring or testing processes involving enzymes, nucleic acids or micro-organisms; Compositions therefor; Processes of preparing such compositions involving viable micro-organisms
- C12Q1/04—Determining presence or kind of micro-organism; Use of selective media for testing antibiotics or bacteriocides; Compositions containing a chemical indicator therefor
Similar Documents
Publication | Publication Date | Title |
---|---|---|
Alborn Jr et al. | Daptomycin disrupts membrane potential in growing Staphylococcus aureus | |
Brock et al. | Probable identity of a group D hemolysin with a bacteriocine | |
O'hara et al. | Maintenance of intracellular pH and acid tolerance in Rhizobium meliloti | |
Beaven et al. | The mechanism of the calcium signal and correlation with histamine release in 2H3 cells. | |
Breukink et al. | Use of the cell wall precursor lipid II by a pore-forming peptide antibiotic | |
Basinger et al. | Bacteriocin (hemolysin) of Streptococcus zymogenes | |
Hagihira et al. | Studies on the glucose-transport system in Escherichia coli with α-methylglucoside as substrate | |
Raynaud et al. | Mechanisms of pyrazinamide resistance in mycobacteria: importance of lack of uptake in addition to lack of pyrazinamidase activity | |
Meyer-Rosberg et al. | The effect of environmental pH on the proton motive force of Helicobacter pylori | |
Fields et al. | Effects of colicins E1 and K on transport systems | |
Leive | Studies on the permeability change produced in coliform bacteria by ethylenediaminetetraacetate | |
Poolman et al. | Regulation of the glutamate-glutamine transport system by intracellular pH in Streptococcus lactis | |
Hand et al. | Uptake of antibiotics by human alveolar macrophages | |
Zajdel et al. | Mechanism of action of lactostrepcin 5, a bacteriocin produced by Streptococcus cremoris 202 | |
Eisenberg et al. | Quantitative association between electrical potential across the cytoplasmic membrane and early gentamicin uptake and killing in Staphylococcus aureus | |
Dore et al. | Different penicillin‐binding protein profiles in amoxicillin‐resistant Helicobacter pylori | |
Mates et al. | Membrane potential in anaerobically growing Staphylococcus aureus and its relationship to gentamicin uptake | |
Leviton et al. | Tobramycin uptake in Escherichia coli membrane vesicles | |
Feingold | The mechanism of colicin E 1 action | |
Santos et al. | Ion channel activity by Pichia membranifaciens killer toxin | |
Lochner et al. | Defective triggering of polymorphonuclear leukocyte oxidative metabolism by Legionella pneumophila toxin | |
Pearson | Culture methods for Proteus mirabilis | |
Tokuda et al. | In vitro depolarization of Escherichia coli membrane vesicles by colicin Ia | |
McMurry et al. | Susceptible Escherichia coli cells can actively excrete tetracyclines | |
Damper et al. | Thallous ion is accumulated by potassium transport systems in Escherichia coli |